Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Debt / NOTE 3.000%12/0
-
Market price (% of par)
-
114.01%
-
Total 13F principal
-
$106,054,284
-
Principal change
-
-$12,634,466
-
Total reported market value
-
$121,191,692
-
Number of holders
-
21
-
Value change
-
-$14,444,016
-
Number of buys
-
11
-
Number of sells
-
6
Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 as of Q2 2015
As of 30 Jun 2015,
ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 was held by
21 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$106,054,284
in principal (par value) of the bond.
The largest 10 bondholders included
Citadel Advisors LLC, WOLVERINE ASSET MANAGEMENT LLC, Hudson Bay Capital Management LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, LAZARD ASSET MANAGEMENT LLC, GUARDIAN LIFE INSURANCE CO OF AMERICA, PERCEPTIVE ADVISORS LLC, Visium Asset Management, LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, and PENN CAPITAL MANAGEMENT CO INC.
This page lists
21
institutional bondholders reporting positions
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.